ORAL ANTIHISTAMINE OR NASAL STEROID IN HAY-FEVER - A DOUBLE-BLIND DOUBLE-DUMMY COMPARATIVE-STUDY OF ONCE DAILY ORAL ASTEMIZOLE VS TWICE DAILY NASAL BECLOMETHASONE DIPROPIONATE

被引：42

|

作者：

WOOD, SF

机构：

来源：

CLINICAL ALLERGY | 1986年 / 16卷 / 03期

关键词：

D O I：

10.1111/j.1365-2222.1986.tb00766.x

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：195 / 201

页数：7

相关论文

共 50 条

[31] A DOUBLE-BLIND GROUP COMPARATIVE-STUDY OF OPHTHALMIC SODIUM CROMOGLYCATE, 2-PERCENT 4 TIMES DAILY AND 4-PERCENT TWICE-DAILY, IN THE TREATMENT OF SEASONAL ALLERGIC CONJUNCTIVITIS
LEINO, M
MONTAN, P
NJA, F
ALLERGY, 1994, 49 (03) : 147 - 151
[32] Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial
O'Riordan, William
Cardenas, Carrie
Shin, Elliot
Sirbu, Alissa
Garrity-Ryan, Lynne
Das, Anita F.
Eckburg, Paul B.
Manley, Amy
Steenbergen, Judith N.
Tzanis, Evan
McGovern, Paul C.
Loh, Evan
LANCET INFECTIOUS DISEASES, 2019, 19 (10): : 1080 - 1090
[33] Once Daily Dosing of 9mg Budesonide (Budenofalk®) Is Therapeutic Equivalent to a Three-Times Daily Dosing of 3mg Budesonide for the Treatment of Active Crohn's Disease: A Randomized, Double-Blind, Double-Dummy, Multicenter Phase III Study
Dignass, Axel U.
Stoynov, Simeon
Dorofeyev, Andrey E.
Grigorieva, Galina A.
Tomsova, Eva
Altorjay, Istvan
Tuculanu, Daniel
Bunganic, Ivan
Pokrotnieks, Juris
Kupcinskas, Limas
Greinwald, Roland
Mueller, Ralph
GASTROENTEROLOGY, 2013, 144 (05) : S233 - S233
[34] Effectiveness and tolerability of once-daily nimesulide versus ibuprofen in pain management after surgical extraction of an impacted third molar:: A 24-hour, double-blind, randomized, double-dummy, parallel-group study
Bocanegra, M
Seiias, A
Yibirín, MG
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2005, 66 (03): : 172 - 180
[35] A Random-Assignment, Double-Blind, Clinical Trial of Once- vs Twice-Daily Administration of Quetiapine Fumarate in Patients with Schizophrenia or Schizoaffective Disorder: A Pilot Study
Chengappa, K. N. Roy
Parepally, Haranath
Brar, Jaspreet S.
Mullen, Jamie
Shilling, Ann
Goldstein, Jeffrey M.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (03): : 187 - 194
[36] Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study
van Zyl-Smit, Richard N.
Kruell, Matthias
Gessner, Christian
Gun, Yasuhiro
Noga, Oliver
Richard, Alexia
de los Reyes, Amy
Shu, Xu
Pethe, Abhijit
Tanase, Ana-Maria
D'Andrea, Peter
LANCET RESPIRATORY MEDICINE, 2020, 8 (10): : 987 - 999
[37] Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A β-haemolytic streptococcal pharyngitis/tonsillitis in adults and adolescents: a double-blind, double-dummy study
Jorgensen, D. M.
CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (12) : 1103 - 1110
[38] Higher Initial Exposure of Envarsus Immediately Post Transplantation Is Not Associated With Increased Risk of Delayed Graft Function in Kidney Transplant Patients Treated With Novel Once-Daily MeltDose Tacrolimus (Envarsus) Vs. Twice-Daily Tacrolimus (Prograf): Results From a Phase 3, Double-Blind, Double-Dummy, Multi-Center, Randomized Trial
Budde, K.
Silva, H.
Steinberg, S.
Kamar, N.
TRANSPLANTATION, 2014, 98 : 460 - 460
[39] Higher Initial Exposure of Envarsus Immediately Post Transplantation Is Not Associated With Increased Risk of Delayed Graft Function in Kidney Transplant Patients Treated With Novel Once-Daily MeltDose Tacrolimus (Envarsus) Vs. Twice-Daily Tacrolimus (Prograf): Results From a Phase 3, Double-Blind, Double-Dummy, Multi-Center, Randomized Trial
Budde, K.
Silva, H.
Steinberg, S.
Kamar, N.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 460 - 460
[40] Randomised, double-blind, phase 2, multicentre study of once daily oral CHS131 in treatment-naive subjects with relapsing-remitting Multiple Sclerosis
Weinstein, D.
Boyko, A.
Pugliese, L.
Tang, H.
Zivadinov, R.
Finck, B.
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 864 - 865

← 1 2 3 4 5 →